Specificity of DNA ADP-Ribosylation Reversal by NADARs
Toxins · 2024
DOI: 10.3390/toxins16050208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Bara Cihlova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK. Hauptthemen laut MEDLINE: ADP-Ribosylation, Escherichia coli. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oxford University Challenge Seed Fund, Biotechnology and Biological Sciences Research Council, Cancer Research UK.
Abstract (Originalsprache)
Recent discoveries establish DNA and RNA as bona fide substrates for ADP-ribosylation. NADAR (“NAD- and ADP-ribose”-associated) enzymes reverse guanine ADP-ribosylation and serve as antitoxins in the DarT-NADAR operon. Although NADARs are widespread across prokaryotes, eukaryotes, and viruses, their specificity and broader physiological roles remain poorly understood. Using phylogenetic and biochemical analyses, we further explore de-ADP-ribosylation activity and antitoxin functions of NADAR domains. We demonstrate that different subfamilies of NADAR proteins from representative E. coli strains and an E. coli-infecting phage retain biochemical activity while displaying specificity in providing protection from toxic guanine ADP-ribosylation in cells. Furthermore, we identify a myxobacterial enzyme within the YbiA subfamily that functions as an antitoxin for its associated DarT-unrelated ART toxin, which we termed YarT, thus presenting a hitherto uncharacterised ART-YbiA toxin–antitoxin pair. Our studies contribute to the burgeoning field of DNA ADP-ribosylation, supporting its physiological relevance within and beyond bacterial toxin–antitoxin systems. Notably, the specificity and confinement of NADARs to non-mammals infer their potential as highly specific targets for antimicrobial drugs with minimal off-target effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
- Division of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
ORCID-Profile: Bara Cihlova, Marion Schuller, Ivan Ahel
Förderung
- Oxford University Challenge Seed Fund
- Biotechnology and Biological Sciences Research Council
- Cancer Research UK
- Ovarian Cancer Research Alliance
- Wellcome Trust
- Cancer Research United Kingdom
- Goodger and Schorstein Scholarships Trust Fund
Zitieren
APA
Cihlova, B., Lu, Y., Mikoč, A., Schuller, M., & Ahel, I. (2024). Specificity of DNA ADP-Ribosylation Reversal by NADARs. Toxins. https://doi.org/10.3390/toxins16050208
Vancouver
Cihlova B, Lu Y, Mikoč A, Schuller M, Ahel I. Specificity of DNA ADP-Ribosylation Reversal by NADARs. Toxins. 2024. doi:10.3390/toxins16050208
BibTeX
@article{Cihlova2024,
author = {Cihlova, Bara and Lu, Yang and Mikoč, Andreja and Schuller, Marion and Ahel, Ivan},
title = {Specificity of DNA ADP-Ribosylation Reversal by NADARs},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16050208}
}
EUVIMED